Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. - Wikidata - wikimedia - TriplyDB

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.

http://www.wikidata.org/entity/Q43637908

about

Antiviral resistance and the control of pandemic influenza Only slight impact of predicted replicative capacity for therapy response prediction Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population First line treatment response in patients with transmitted HIV drug resistance and well defined time point of HIV infection: updated results from the German HIV-1 seroconverter study HIV-1 drug resistance and resistance testing.Transmitted drug resistance in nonsubtype B HIV-1 infection.Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors.Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene Primary drug resistance in South Africa: data from 10 years of surveys.Ambulatory care for HIV-infected patients: differences in outcomes between hospital-based units and private practices: analysis of the RESINA cohort.HIV-1 antiretroviral resistance: scientific principles and clinical applications HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study.Differential persistence of transmitted HIV-1 drug resistance mutation classes.Predictors of disease progression in HIV infection: a review.Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.Efavirenz: a review.Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.Molecular assays for monitoring HIV infection and antiretroviral therapy.Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations.Estimating the prevalence of transmitted HIV drug resistance using pooled samples.Evolutionary pathways of transmitted drug-resistant HIV-1.Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan.Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey.Low HIV-1 transmitted drug resistance in Bulgaria against a background of high clade diversity.HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection.Transmission cluster of multiclass highly drug-resistant HIV-1 among 9 men who have sex with men in Seattle/King County, WA, 2005-2007.Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings

P2860

Q28469119-F024A23A-2F7C-44D5-94FF-C8464C74E6E8 Q28472749-B38992D8-0C7D-457C-ABB7-8E4A9CE77ED1 Q28475698-68F51CBB-B1DA-4927-8F45-55C5F07F3F1B Q28477624-06FA9766-F388-4BCE-825C-54084CFAEB6D Q28538326-79CBB8F0-87E6-46FC-8F3F-3077BB6916B3 Q30245693-DE1C3B37-DB32-4728-A7F4-63B025BEAFAB Q33567164-BC347362-291A-4FF0-8D31-697657FF2B4E Q33601530-829A8C6D-0537-4527-BABE-F825345870E2 Q34118276-B7CE182E-3C1C-4FE5-AAA0-CD7B3A412DCA Q34129300-C14D790A-8115-4499-9F32-6347D19AAD1B Q34253604-CEDE956B-06AA-4A50-8195-9AA48C527F28 Q34280466-35F2F975-95F3-45DD-9BAF-4A44AEC622B8 Q34756828-FF0DAD26-153F-4D25-AE4D-9ABB2BFB984D Q35022802-84C83E2D-C98A-4E12-A357-93742DB2F63A Q35834337-54F01312-6E41-4D16-A022-6BC77E9E78A5 Q35913936-84BDAA58-0696-4389-A5F2-E80AE4F68D95 Q36104509-82573285-1F42-4C00-9ED4-6737C44C681F Q36696351-E8259B3F-EE33-4CA9-B0F9-62679EF83B9D Q36787311-6AA1D4F9-3069-4527-B7A6-D04014E8BA0E Q36798007-590E71AC-B61D-4070-BC97-6F422315F49B Q36816024-85B947E2-40CF-4842-9CCA-043F29F0B191 Q36900951-33BE146F-DB91-4AB0-A786-25535AF645E4 Q36949610-2D2B5CCD-56DB-4A6D-AD08-373FB6A82A64 Q37714506-C7EE18A4-C54B-4FEF-A4DC-27408AEF75C3 Q37866540-BFF4040D-88E1-4BBC-87AA-5BDBC65171B2 Q38405467-DAFC2640-F777-4FB0-8195-D3E90C82E167 Q39080507-0CEE5897-8626-4106-A288-E54D106C7C3B Q41009267-C389C7DB-3BCF-4A51-A036-F132AD71B9F7 Q41477527-8FB11897-7053-43B7-AE73-8936D28CE603 Q42286083-73927AA6-3432-433D-88DB-79783FCF5DDA Q43239908-96A53E96-5445-4BC6-8EA3-5D0D80C60732 Q46000779-B1561AB2-AFA0-42CB-BE6B-DCFD2E28A39F Q57708766-92F19313-BA6F-41AB-9040-21A0D19743C2 Q57880269-24A7DCAD-0BA3-49D3-B389-58E92BD6EDDC

P2860

Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.

http://www.wikidata.org/entity/Q43637908

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Primary HIV drug resistance an ...... guided by resistance testing.

@en

Primary HIV drug resistance an ...... guided by resistance testing.

@nl

type

label

Primary HIV drug resistance an ...... guided by resistance testing.

@en

Primary HIV drug resistance an ...... guided by resistance testing.

@nl

prefLabel

Primary HIV drug resistance an ...... guided by resistance testing.

@en

Primary HIV drug resistance an ...... guided by resistance testing.

@nl

P1433

Q43637908-16211F02-CAC0-4F7E-9182-7BF2A68F11F3

P1476

Q43637908-54E3BC86-34ED-4656-ADEE-00E21991082C

P2093

Q43637908-0283DED4-2957-436A-A6E2-6B40F65E31EC

Q43637908-2C5C2B76-1677-4609-926D-9EE254BEE26E

Q43637908-53FE6D0F-6BB4-4B26-B166-E59B0042C330

Q43637908-71393F99-E538-48B1-8968-ACF1087F4E25

Q43637908-8DDEDC4C-6A26-4BCE-AAA4-0783A6EA2CF4

Q43637908-A2B16A84-FC4B-430D-B16A-22A226D1E2A8

Q43637908-A4394329-86AD-46A7-B158-1C00742A24D3

Q43637908-E3C1F056-4795-47BB-A3A3-F362B5B05996

Q43637908-E562E65F-4F67-4DA0-9D73-75FB96B0AEA3

Q43637908-F65FB70C-BA25-4FB5-86CB-169C42511582

P304

Q43637908-B15C8684-83D5-4B05-8D1C-F762A9352676

P31

Q43637908-42B87C34-09D6-4A0A-AF1D-F423BC9BA2B7

P356

Q43637908-DDAE4563-F815-4DE7-94BC-44314A345B50

P407

Q43637908-63F89C61-50F0-4BE1-8E16-82EEA5A9B5E1

P433

Q43637908-5D8195A8-A847-44C6-9873-F14EB5BB8986

P478

Q43637908-A3DCB3A2-C046-46A1-8CC1-1B0585EEE9B9

P50

Q43637908-459F0021-6A2C-40E2-8D8B-7BE9F60BC80D

Q43637908-59AE93B9-87D0-43C9-868B-BBE2649A9D5C

Q43637908-ADD54BF0-03C2-46AA-8638-7F0678055873

P577

Q43637908-79BACCF4-0ED0-4C68-9817-69CEFAA4689D

P698

Q43637908-C52762CA-2F9F-4C2C-9368-28BDC8573753

P356

01.QAI.0000214805.52723.C1

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Primary HIV drug resistance an ...... guided by resistance testing.

@en

P2093

Dirk Schmalöer

http://www.w3.org/2001/XMLSchema#string

Herbert Pfister

http://www.w3.org/2001/XMLSchema#string

Horst Carls

http://www.w3.org/2001/XMLSchema#string

Jürgen Kurt Rockstroh

http://www.w3.org/2001/XMLSchema#string

Jürgen Stechel

http://www.w3.org/2001/XMLSchema#string

Mark Oette

http://www.w3.org/2001/XMLSchema#string

Martin Däumer

http://www.w3.org/2001/XMLSchema#string

Rolf Kaiser

http://www.w3.org/2001/XMLSchema#string

Ruth Petch

http://www.w3.org/2001/XMLSchema#string

Torsten Feldt

http://www.w3.org/2001/XMLSchema#string

P304

573-581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.QAI.0000214805.52723.C1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P50

Dieter Häussinger

Gerd Fätkenheuer

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16652031

http://www.w3.org/2001/XMLSchema#string